Opinion

Video

More Is Needed to Connect Clinicians, Patients to Clinical Trials

Author(s):

More facilitation is needed to ensure that clinicians can connect patients with breast cancer to clinical trials they may be eligible for.

More needs to be done to facilitate a connection between oncology nurse navigators and clinical resources to improve enrollment and diversify the patient population involved in research, explained Sue Friedman.

In an interview with CURE®, Friedman, who is the executive director of FORCE (Facing Hereditary Cancer Empowered) discussed a needs assessment conducted by FORCE and supported by the Centers of Disease Control and Prevention (CDC), which highlighted barriers for referrals to supportive care services and clinical trials for young patients with breast cancer.

READ MORE: Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials

Now, Friedman explained, FORCE will work to facilitate that collaboration to improve clinical trial enrollment and break down barriers to supportive care, such as fertility preservation.

Transcript

Well, there were several big takeaways from our needs assessment, and this poster was really just one component of it, but one was that there was more that we could do as an organization to facilitate connecting oncology nurse navigators with resources around clinical research studies to help encourage them to let patients know more about clinical research studies in order to improve enrollment and diverse involvement in clinical research.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content